SAVR
SAVR is a medical device with 10 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
5
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
ASAN Medical Center Aortic Valve Replacement Registry
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
Clinical Trials (10)
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
ASAN Medical Center Aortic Valve Replacement Registry
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
Subclinical Aortic Valve Bioprosthesis Thrombosis Assessed With 4D CT
Evaluation of BAV in Different Hemodynamic Entities of Severe AS
Validation of the "TASQ" in Patients Undergoing SAVR or TF-TAVI
The Safety and Effectiveness of Transcatheter Aortic Valve Raplacemet in Intermediate Risk Patients With Bicuspid Aortic Stenosis
TRANscatheter or SurgIcal Aortic Valve ReplacemenT in All-Comers With Severe Aortic Valve Stenosis
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10